Related Experiment Video
Updated: Dec 7, 2025
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Small vessel coronary artery disease: How small can we go with myocardial revascularization?
Maciej T Wybraniec1,2, Paweł Bańka3,4, Tomasz Bochenek3,4
1First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland. maciejwybraniec@gmail.com.
Insights
Small coronary artery atherosclerosis poses risks and lacks clear definition. New treatments like drug-coated balloons and conservative approaches are emerging options for managing this condition.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Disease
Background:
- Small coronary artery atherosclerosis is linked to increased procedural complications and poorer long-term outcomes in coronary artery disease.
- A lack of a clear definition for small coronary vessels complicates diagnosis and treatment strategies.
- Recent research has shed light on potential therapeutic advancements for this specific condition.
Purpose of the Study:
- To provide a comprehensive overview of the definition, interventional management, and prognosis of small coronary artery atherosclerosis.
- To discuss novel treatment options for small coronary vessels.
- To contextualize current therapeutic strategies based on recent clinical trial data.
Main Methods:
- Review of recent randomized controlled trials.
- Analysis of data regarding drug-coated balloons versus drug-eluting stents.
- Consideration of conservative management strategies, including insights from the ISCHEMIA trial.
Main Results:
- Emerging evidence suggests drug-coated balloons as a potential alternative to drug-eluting stents for small coronary vessels.
- Conservative management is a viable therapeutic option, supported by recent trial outcomes.
- Improved understanding of small coronary artery atherosclerosis is crucial for patient outcomes.
Conclusions:
- Accurate definition and tailored management strategies are essential for addressing small coronary artery atherosclerosis.
- Novel interventional and conservative approaches offer promising therapeutic avenues.
- Further research is needed to optimize the treatment and prognosis of patients with small coronary artery disease.
Abstract:
The issue of small coronary artery atherosclerosis represents an intriguing aspect of coronary artery disease, which is related with higher rates of peri- and post-procedural complications and impaired long-term outcome. This problem is further complicated by the unclear definition of small coronary vessel. Recent randomized controlled trials have provided new data on possible novel interventional treatment of small coronary vessels with drug-coated balloons instead of traditional new-generation drug-eluting stent implantation. Also, the conservative management represents a therapeutic option in light of the results of the recent ISCHEMIA trial. The current article provides an overview of the most appropriate definition, interventional management, and prognosis of small coronary artery atherosclerosis.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
01:26Coronary Artery Disease II: Pathophysiology
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:30Coronary Artery Disease III: Clinical Manifestations
01:30Coronary Artery Disease I: Introduction